C

Coya Therapeutics Inc
NASDAQ:COYA

Watchlist Manager
Coya Therapeutics Inc
NASDAQ:COYA
Watchlist
Price: 5.505 USD -0.09% Market Closed
Market Cap: 92m USD
Have any thoughts about
Coya Therapeutics Inc?
Write Note

Wall Street
Price Targets

COYA Price Targets Summary
Coya Therapeutics Inc

Wall Street analysts forecast COYA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for COYA is 17.51 USD with a low forecast of 15.655 USD and a high forecast of 18.9 USD.

Lowest
Price Target
15.655 USD
184% Upside
Average
Price Target
17.51 USD
218% Upside
Highest
Price Target
18.9 USD
243% Upside
Coya Therapeutics Inc Competitors:
Price Targets
ORKA
Oruka Therapeutics Inc
250% Upside
ORY
Oryzon Genomics SA
170% Upside
ONCO
Oncopeptides AB
296% Upside
RYTM
Rhythm Pharmaceuticals Inc
37% Upside
CRSP
CRISPR Therapeutics AG
80% Upside
ARMP
Armata Pharmaceuticals Inc
376% Upside
FHTX
Foghorn Therapeutics Inc.
121% Upside
300685
Amoy Diagnostics Co Ltd
46% Upside

Revenue
Forecast

Revenue Estimate
Coya Therapeutics Inc

The compound annual growth rate of Coya Therapeutics Inc's revenue for the next 3 years is 53%.

N/A
Past Growth
53%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Coya Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Coya Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-46%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is COYA's stock price target?
Price Target
17.51 USD

According to Wall Street analysts, the average 1-year price target for COYA is 17.51 USD with a low forecast of 15.655 USD and a high forecast of 18.9 USD.

What is Coya Therapeutics Inc's Revenue forecast?
Projected CAGR
53%

The compound annual growth rate of Coya Therapeutics Inc's revenue for the next 3 years is 53%.

Back to Top